Reversible neutropenia during treatment with olanzapine: Three case reports

World Journal of Biological Psychiatry

Volumn 5, Issue 4, 2004, Pages 230-234

  Cordes, Joachim ^a   Streit, Marcus ^a   Loeffler, Stefan ^a   von Wilmsdorff, Martina ^a   Agelink, Marcus ^b   Klimke, Ansgar ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Neutropenia; Olanzapine; Side effects

Indexed keywords

ACETYLCYSTEINE; AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BISOPROLOL FUMARATE; CEFALEXIN; CLOZAPINE; HALOPERIDOL; LORAZEPAM; METIXENE; NEUROLEPTIC AGENT; NIFEDIPINE; OLANZAPINE; RISPERIDONE; SERTINDOLE; BENZODIAZEPINE DERIVATIVE;

ADULT; AGGRESSIVENESS; AGRANULOCYTOSIS; ARTICLE; BRONCHITIS; CASE REPORT; CATATONIC SCHIZOPHRENIA; DELUSION; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GERMANY; HUMAN; HYPERKINESIA; HYPERTENSION; INCIDENCE; LEUKOPENIA; MALE; NEUTROPENIA; NEUTROPHIL COUNT; NOSE FRACTURE; NOSE INFECTION; PATIENT COMPLIANCE; PNEUMONIA; SCHIZOPHRENIA; AGED; ATROPHY; CHEMICALLY INDUCED DISORDER; FRONTAL LOBE; PARIETAL LOBE; PATHOLOGY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; ATROPHY; BENZODIAZEPINES; CLOZAPINE; FEMALE; FRONTAL LOBE; HUMANS; NEUTROPENIA; PARIETAL LOBE; SCHIZOPHRENIA;

EID: 16644369092     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970410029938     Document Type: Article

References (18)

1. Bankowski, Z and Bruppacher, R and Crusius, I and Gallagher, J and Kremer, G and Venulet, J. (1999). Reporting Adverse Drug Reaction. Council for International Organization of Medical Sciences (CIOMS). In [pp. 100]. printed in Switzerland 1
2. Beasley, C. (1997) Efficacy of olanzapine: An overview of pivotal clinical trial J Clin Psychiatry Monograph, 15, pp. 16-21.
3. Beasley, C and Tollefson, G and Tran, P. (1997) Safety of olanzapine J Clin Psychiatry, 58(Suppl 10), pp. 13-17.
4. Bundesärztekammer. (2001) Arzneimittelkommission der deutschen Ärzteschaft-Blutbildveränderungen unter dem neueren atypischen Neuroleptikum Olanzapin Deutsches Ärzteblatt, 98(Heft 3), pp. A-130.
5. Benedetti, F and Cavallaro, R and Smeraldi, E. (1999) Olanzapine-induced neutropenia after clozapine-induced neutropenia Lancet, 354, pp. 567.
6. Dale, D and Hammond, W, 4th. (1988) Cyclic neutropenia: A clinical review Blood Rev Sep, 2, pp. 178-185.
7. Kodesh, A and Finkel, B and Lerner, A and Kretzmer, G and Sigal, M. (2001) Dosedependent olanzapine-associated leukopenia: Three case reports Int Clin Psychopharmacol, 16, pp. 117-119.
8. Lambert, T. (1998) Olanzapine after clozapine: The rare case of prolongation of granulocytopenia Aust N Z J Psychiatry, 32, pp. 591-592.
9. Loeffler, S and Fehsel, K and Henning, U and Fischer, J and Agelink, M and Kolb-Bachofen, V and Klimke, A. (2003) Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis Pharmacopsychiatry, 36, pp. 37-41.
10. Meissner, W and Schmidt and Kupsch, A and Trottenberg, T and Lempert, T. (1999) Reversible leucopenia related to olanzapine Mov Disord, 14, pp. 872-873.
11. Naumann, R and Felber, W and Heilemann, H and Reuster, T. (1999) Olanzapininduced agranulocytosis Lancet, 354, pp. 566-567.
12. Oyewumi, L and Semaan, Y. (2000) Olanzapine: Safe during clozapineinduced agranulocytosis J Clin Psychopharmacol, 20, pp. 279-281.
13. Sartorius, N and Fleischhacker, W and Gjerris, A and Kern, U and Knapp, M and Leonard, B and Liebermann, J and Lopez-Ibor, J and Raay, B and Tornquist, E and Twomey, E. (2003) The usefulness and use of second-generation antipsychotic medications-an update Current Opinion in Psychiatry, 16(Suppl 1), pp. 7-17.
14. Stuebner, S and Grohmann, R and Engel, R and Bandelow, B and Ludwig, W and Wagner, G and Mueller-Oerlinghausen, B and Moeller, H and Hippius, H and Ruether, E. (2004) Blood dyscrasias induced by psychotropic drugs Pharmacopsychiatry, 37(Suppl 1), pp. 70-78.
15. Steinwachs, A and Grohmann, R and Petrosa, F and Ruether, E and Schwerdtner, I. (1999) Two cases of olanzapine-induced reversible neutropenia Pharmacopsychiatry, 32, pp. 154-156.
16. Swartz, R and Ananth, J and Smith, M and Burgoyne, K and Gadasally, R and Arai, Y. (1999) Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients J Clin Psychiatry, 60, pp. 119-121.
17. Tran, P and Hamilton, S and Kuntz, A and Potvin, J and Andersen, S and Beasley C, Jr and Tollefson, G. (1997) Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders J Clin Psychopharmacol, 17, pp. 407-418.
18. Voth, A and Turner, R. (1983) Nifedipine and agranulocytosis Ann Intern Med, 99, pp. 882.